Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Elevations in Liver Transaminases in COVID-19: (How) Are They Related?

Full text
Author(s):
Pott-Junior, Henrique [1] ; Bittencourt, Natalia Queiroz Prado [1] ; Chacha, Silvana F. G. [1] ; Luporini, Rafael Luis [1, 2] ; Cominetti, Marcia Regina [3] ; Anibal, Fernanda de Freitas [2, 4]
Total Authors: 6
Affiliation:
[1] Univ Fed Sao Carlos, Dept Med, Sao Carlos - Brazil
[2] Univ Fed Sao Carlos, Biotechnol Grad Program, Sao Carlos - Brazil
[3] Univ Fed Sao Carlos, Dept Gerontol, Sao Carlos - Brazil
[4] Univ Fed Sao Carlos, Dept Biol Sci Parasitol, Sao Carlos - Brazil
Total Affiliations: 4
Document type: Journal article
Source: FRONTIERS IN MEDICINE; v. 8, JUL 15 2021.
Web of Science Citations: 0
Abstract

Liver involvement in COVID-19 is not yet well-understood, but elevations in liver transaminases have been described to occur in 14-53% of the cases and are more frequently seen in severe disease. This cross-sectional study explored the relationship between the elevations in liver transaminases and inflammatory parameters in 209 adults with COVID-19. Demographic and clinical data, serum levels of inflammatory cytokines and liver aminotransferases were analyzed. Three groups were formed according to the liver transaminase abnormalities: (I) Normal transaminases, (II) Borderline transaminases elevation, and (III) Mild to severe transaminases elevation. Altered liver transaminases were directly related to disease severity, showing association with the NEWS2 score at admission and greater need for ICU or death. Moreover, higher levels of IL-2 and CRP were associated with borderline transaminases elevations, whereas higher levels of IL-10 and Neutrophil to Lymphocyte ratio were associated with mild to severe transaminases elevation. These results reinforce the importance of liver transaminases in patients with COVID-19 as a complementary marker for disease severity and also point to them as a parameter reflecting the continuous dynamics between viral infection and the immune response. (AU)

FAPESP's process: 14/50867-3 - INCT 2014: National Institute of Science and Technology in Bioanalysis
Grantee:Marco Aurelio Zezzi Arruda
Support Opportunities: Research Projects - Thematic Grants